The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The Amino zing World of Peptide Regulation ArentFox Schiff Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review